Clinical trial
Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
NCT00003697 · University of Glasgow, Other · Completed
Key facts
| NCT number | NCT00003697 |
|---|---|
| Title | Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors |
| Official title | A Phase I Trial of 5, 6 Dimethyl Xanthenone - 4 - Acetic Acid (DMXAA) in Solid Tumors |
| Lead sponsor | University of Glasgow, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | vadimezan |
| Enrollment | 3 |
| Start date | Oct 1, 1995 |
| Completion | Dec 1, 1998 |
| First posted | May 20, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: